AR113618A1 - Péptidos antimicrobianos y métodos para usarlos - Google Patents
Péptidos antimicrobianos y métodos para usarlosInfo
- Publication number
- AR113618A1 AR113618A1 ARP180103579A ARP180103579A AR113618A1 AR 113618 A1 AR113618 A1 AR 113618A1 AR P180103579 A ARP180103579 A AR P180103579A AR P180103579 A ARP180103579 A AR P180103579A AR 113618 A1 AR113618 A1 AR 113618A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- antimicrobial peptides
- peptides
- antimicrobial
- animal
- Prior art date
Links
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 206010040872 skin infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762595725P | 2017-12-07 | 2017-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR113618A1 true AR113618A1 (es) | 2020-05-20 |
Family
ID=65003464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103579A AR113618A1 (es) | 2017-12-07 | 2018-12-06 | Péptidos antimicrobianos y métodos para usarlos |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US11352396B2 (https=) |
| EP (2) | EP4656726A3 (https=) |
| JP (1) | JP7381465B2 (https=) |
| KR (3) | KR102555177B1 (https=) |
| CN (1) | CN111479824A (https=) |
| AR (1) | AR113618A1 (https=) |
| AU (3) | AU2018378035B2 (https=) |
| BR (1) | BR112020009973A2 (https=) |
| CA (1) | CA3082491A1 (https=) |
| CL (1) | CL2020001464A1 (https=) |
| CO (1) | CO2020006907A2 (https=) |
| DK (1) | DK3720875T3 (https=) |
| ES (1) | ES3041688T3 (https=) |
| FI (1) | FI3720875T3 (https=) |
| HU (1) | HUE072916T2 (https=) |
| IL (2) | IL275074B2 (https=) |
| LT (1) | LT3720875T (https=) |
| MX (1) | MX2020005920A (https=) |
| NZ (1) | NZ764838A (https=) |
| PH (1) | PH12020550942A1 (https=) |
| PL (1) | PL3720875T3 (https=) |
| PT (1) | PT3720875T (https=) |
| SG (1) | SG11202004661QA (https=) |
| SI (1) | SI3720875T1 (https=) |
| TW (2) | TWI786887B (https=) |
| WO (1) | WO2019113181A1 (https=) |
| ZA (1) | ZA202003387B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220307048A1 (en) * | 2021-03-23 | 2022-09-29 | Genvor Inc. | Antimicrobial peptides |
| CN113185576B (zh) * | 2021-04-09 | 2023-05-30 | 倪京满 | 一类具有RRRF转角的β-发卡型低毒广谱抗菌肽及其应用 |
| US20250042946A1 (en) | 2021-12-08 | 2025-02-06 | Oakgrove Bio Llc | Biological Production of Histidine-Rich Peptides |
| EP4198045A1 (en) * | 2021-12-16 | 2023-06-21 | Université de Lille | Antimicrobial peptides, variants and chemical analogues thereof and their uses |
| WO2024003890A1 (en) * | 2022-06-29 | 2024-01-04 | Omnix Medical Ltd. | Novel peptide for treating an infectious disease or condition |
| CN120309697B (zh) * | 2025-06-13 | 2025-09-02 | 四川大学 | 一种用于抗革兰氏阴性菌的多肽药物及应用 |
| CN121378418B (zh) * | 2025-12-26 | 2026-04-03 | 四川大学 | 一组针对革兰氏阴性菌的抗菌多肽 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1323166C (zh) * | 2003-09-18 | 2007-06-27 | 中国农业科学院饲料研究所 | 一种鲎素的基因及表达其的方法 |
| CN101307316B (zh) * | 2008-07-22 | 2011-03-16 | 北京中农颖泰生物技术有限公司 | 抗菌肽cad在枯草杆菌中的分泌表达及重组枯草杆菌表达系统 |
| CN101698682B (zh) * | 2009-10-26 | 2012-05-23 | 陕西省微生物研究所 | 一种基于抗菌肽的双功能融合蛋白及其制备方法和用途 |
| CN101817883B (zh) * | 2010-03-12 | 2012-06-13 | 广东药学院 | 一种家蝇天蚕素-人溶菌酶融合蛋白及其制备方法和应用 |
| CN101851620B (zh) * | 2010-04-21 | 2012-05-23 | 吉林农业大学 | 利用食药用菌生产FGFs的方法 |
| CA2890357C (en) * | 2011-07-13 | 2024-01-09 | Solarvest BioEnergy Inc. | Methods and uses of a modified cecropin for treating endoparasitic and bacterial infections |
| CN104177502B (zh) * | 2014-08-21 | 2018-04-24 | 天津兰瑞生物技术有限公司 | 一种鲎素肽-抗体融合蛋白及制备方法 |
| CN104988170B (zh) * | 2015-08-01 | 2018-01-16 | 吉林农业大学 | 一种融合抗菌肽及其制备方法和应用 |
-
2018
- 2018-11-28 TW TW110138439A patent/TWI786887B/zh active
- 2018-11-28 TW TW107142356A patent/TWI746908B/zh active
- 2018-12-05 EP EP25189644.5A patent/EP4656726A3/en active Pending
- 2018-12-05 SI SI201831260T patent/SI3720875T1/sl unknown
- 2018-12-05 KR KR1020207015602A patent/KR102555177B1/ko active Active
- 2018-12-05 PT PT188305627T patent/PT3720875T/pt unknown
- 2018-12-05 BR BR112020009973-2A patent/BR112020009973A2/pt unknown
- 2018-12-05 CN CN201880078731.4A patent/CN111479824A/zh active Pending
- 2018-12-05 WO PCT/US2018/064029 patent/WO2019113181A1/en not_active Ceased
- 2018-12-05 KR KR1020237023202A patent/KR102713813B1/ko active Active
- 2018-12-05 KR KR1020247032634A patent/KR20240151857A/ko active Pending
- 2018-12-05 US US16/769,025 patent/US11352396B2/en active Active
- 2018-12-05 IL IL275074A patent/IL275074B2/en unknown
- 2018-12-05 CA CA3082491A patent/CA3082491A1/en active Pending
- 2018-12-05 PL PL18830562.7T patent/PL3720875T3/pl unknown
- 2018-12-05 MX MX2020005920A patent/MX2020005920A/es unknown
- 2018-12-05 FI FIEP18830562.7T patent/FI3720875T3/fi active
- 2018-12-05 LT LTEPPCT/US2018/064029T patent/LT3720875T/lt unknown
- 2018-12-05 EP EP18830562.7A patent/EP3720875B1/en active Active
- 2018-12-05 HU HUE18830562A patent/HUE072916T2/hu unknown
- 2018-12-05 JP JP2020531448A patent/JP7381465B2/ja active Active
- 2018-12-05 IL IL312730A patent/IL312730A/en unknown
- 2018-12-05 ES ES18830562T patent/ES3041688T3/es active Active
- 2018-12-05 AU AU2018378035A patent/AU2018378035B2/en active Active
- 2018-12-05 SG SG11202004661QA patent/SG11202004661QA/en unknown
- 2018-12-05 NZ NZ764838A patent/NZ764838A/en unknown
- 2018-12-05 DK DK18830562.7T patent/DK3720875T3/da active
- 2018-12-06 AR ARP180103579A patent/AR113618A1/es unknown
-
2020
- 2020-06-02 CL CL2020001464A patent/CL2020001464A1/es unknown
- 2020-06-03 PH PH12020550942A patent/PH12020550942A1/en unknown
- 2020-06-04 CO CONC2020/0006907A patent/CO2020006907A2/es unknown
- 2020-06-05 ZA ZA2020/03387A patent/ZA202003387B/en unknown
-
2022
- 2022-05-06 US US17/738,572 patent/US12054518B2/en active Active
-
2023
- 2023-09-11 AU AU2023229465A patent/AU2023229465B2/en active Active
-
2024
- 2024-06-18 US US18/746,401 patent/US20250074947A1/en active Pending
- 2024-09-12 AU AU2024219645A patent/AU2024219645A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR113618A1 (es) | Péptidos antimicrobianos y métodos para usarlos | |
| CL2020002019A1 (es) | Composiciones para modular la expresión de c9orf72. (divisional solicitud 201803582) | |
| CO2021001912A2 (es) | Composiciones anti-cd112r y métodos | |
| DOP2019000180A (es) | INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS | |
| CL2015002640A1 (es) | Agentes inductores de la apoptosis para tratar el cáncer y enfermedades inmunes y autoinmunes | |
| BR112019017403A2 (pt) | composições e métodos para o tratamento de câncer | |
| MX2018005315A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| CL2021000855A1 (es) | Replicones basados en alfavirus para la administración de bioterapias. | |
| EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
| MX388978B (es) | Compuestos de biarilo utiles para el tratamiento de enfermedades humanas en oncologia, neurologia e inmunologia | |
| EA201790195A1 (ru) | Способы лечения рака с применением ингибиторов tigit и противораковых агентов | |
| MX395231B (es) | Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos. | |
| MX374365B (es) | Extracto de algas para su uso en calidad de agente inmunomodulador. | |
| CL2019003670A1 (es) | Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta. | |
| MX2020011027A (es) | Constructos de anticuerpos biespecíficos trivalentes. | |
| MX391757B (es) | Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico. | |
| CL2018003104A1 (es) | Uso de nootkatone para tratar piojos de mar. | |
| MX2018013409A (es) | Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido. | |
| JO3565B1 (ar) | الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها | |
| MX381252B (es) | Virus de la enteritis del pato y usos del mismo. | |
| BR112018012883A2 (pt) | novos anticorpos anti-upk1b e métodos de uso | |
| BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso | |
| PY1943738A (es) | Composiciones herbicidas | |
| MX392976B (es) | Composiciones que comprenden cepas bacterianas. | |
| JOP20200126B1 (ar) | طرق استخدام وتركيبات تحتوي على دولاجلوتيد |